New Zealand Brown Marmorated stink bug

MSC container ship in harbor

The New Zealand Ministry for Primary Industries (MPI - Biosecurity) has issued direction for imports during the 2019/20 season of the BMWS. This direction contains new versions of the Import Health Standard for vehicles, machinery and parts and the Import Health Standard for sea containers from all countries. Both standards include major requirement changes for importing goods to New Zealand during the risk season (September to April) from BMSB risk countries. It is important for all importers
and exporters to know the changes before shipping to New Zealand.

MPI have advised they will be constantly updating the requirements throughout the BSMB season. Please check frequently for updates here.

2019 / 2020 season:
- Commences 1st September 2019. Applies to all cargo departing origin port on or from this date
- Ends 30th April 2020. Applies to all cargo arriving to NZ prior to or on this date

Cargo Details:
Target high-risk goods are vehicle, machinery and parts (VAMP) - Offshore treatment is mandatory for all shipment types, LCL/FAK, FCL and Breakbulk Cargo containing VAMP goods. Any shipment that contains target high-risk goods that has not been treated offshore by an approved treatment, the provider will be denied discharged and directed for export on arrival.

Furthermore, offshore treatment is also mandatory for ALL FCL sea containers originating in Italy regardless of the goods contained.
The only mandatory treatment exceptions are for sensitive cargo. The list of risk goods that an MPI considers to be sensitive to treatment are as follows:

• Agricultural compounds and veterinary medicines, Food for human consumption (including beverages) • Fresh produce • Frozen food products • Live animals • Leather goods (apparel and furniture) • Pet food • Pharmaceutical products • Polyurethane bales and foam products • Refrigerated goods • Seed for sowing • Tank-tainers • Textiles (including yarn)

Any customers who are importing target risk goods from target risk countries should be speaking with their overseas suppliers to discuss offshore treatment options. All offshore treatment providers must be approved by MPI. 

Should you require any assistance, please reach out to your local BDP representative.

Sources: BDP International, MPI